Gene · 8115
Papers1,926
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,926
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation. | Blood Cancer J | 2024 | 39198400 | PubTator, text mining | PubMed |
| Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN). | Kidney Int | 2024 | 39197587 | PubTator, text mining | PubMed |
| Robust and cost-effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ-TCL1 model of chronic lymphocytic leukemia. | Hemasphere | 2024 | 39157689 | PubTator, text mining | PubMed |
| Does a subset of mature T-cell leukemias with features akin to T-cell prolymphocytic leukemia but lacking rearrangement of the TCL1 represent peripheral T-cell lymphoma, NOS in a leukemic phase? | EJHaem | 2024 | 39157608 | PubTator, text mining | PubMed |
| Unveiling the Tempest: Dermal Plasmacytoid Dendritic Cell Proliferation as the Harbinger of Acute Myeloid Leukemia. | Am J Dermatopathol | 2024 | 39141714 | PubTator, text mining | PubMed |
| A Novel JAK2 Fusion in T-Cell Prolymphocytic Leukemia. | Genes Chromosomes Cancer | 2024 | 39133763 | PubTator, text mining | PubMed |
| The Sex and Age-Associated Infiltration of B Cells May Result in the Dimorphic Behaviors Observed in Papillary Thyroid Carcinomas. | Int J Gen Med | 2024 | 39055976 | PubTator, text mining | PubMed |
| Plasma proteometabolome in lung cancer: exploring biomarkers through bidirectional Mendelian randomization and colocalization analysis. | Hum Mol Genet | 2024 | 39011643 | PubTator, text mining | PubMed |
| Comparative single-cell transcriptional and proteomic atlas of clinical-grade injectable mesenchymal source tissues. | Sci Adv | 2024 | 38996032 | PubTator, text mining | PubMed |
| [TCL1-family negative T-cell prolymphocytic leukemia with rapid progression of extranodal disease despite a normal white blood cell count]. | Rinsho Ketsueki | 2024 | 38960645 | PubTator, text mining | PubMed |
| Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia. | Am J Clin Pathol | 2024 | 38946194 | PubTator, text mining | PubMed |
| Transparent nanocrystal-in-glass composite fibers for multifunctional temperature and pressure sensing. | Fundam Res | 2024 | 38933183 | PubTator, text mining | PubMed |
| Ragas: integration and enhanced visualization for single cell subcluster analysis. | Bioinformatics | 2024 | 38867706 | PubTator, text mining | PubMed |
| Exosomal mRNA Cargo are biomarkers of tumor and immune cell populations in pediatric osteosarcoma. | Transl Oncol | 2024 | 38852279 | PubTator, text mining | PubMed |
| Lessons learned from the Eµ-TCL1 mouse model of CLL. | Semin Hematol | 2024 | 38839457 | PubTator, text mining | PubMed |
| Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2. | Leuk Lymphoma | 2024 | 38775302 | PubTator, text mining | PubMed |
| BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia. | JCI Insight | 2024 | 38775157 | PubTator, text mining | PubMed |
| TCL1A-expressing B cells are critical for tertiary lymphoid structure formation and the prognosis of oral squamous cell carcinoma. | J Transl Med | 2024 | 38764038 | PubTator, text mining | PubMed |
| Determinants of mosaic chromosomal alteration fitness. | Nat Commun | 2024 | 38714703 | PubTator, text mining | PubMed |
| A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. | Clin Cancer Res | 2024 | 38640040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8115/papers?page=6